留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

在线自适应放疗技术治疗局部进展期宫颈癌一例

王光宇 晏俊芳 汪之群 张宇 孙显松 李晶 李文博 杨波 张福泉

王光宇, 晏俊芳, 汪之群, 张宇, 孙显松, 李晶, 李文博, 杨波, 张福泉. 在线自适应放疗技术治疗局部进展期宫颈癌一例[J]. 协和医学杂志. doi: 10.12290/xhyxzz.2023-0076
引用本文: 王光宇, 晏俊芳, 汪之群, 张宇, 孙显松, 李晶, 李文博, 杨波, 张福泉. 在线自适应放疗技术治疗局部进展期宫颈癌一例[J]. 协和医学杂志. doi: 10.12290/xhyxzz.2023-0076
WANG Guangyu, YAN Junfang, WANG Zhiqun, ZHANG Yu, SUN Xiansong, LI Jing, LI Wenbo, YANG Bo, ZHANG Fuquan. Locally Advanced Cervical Cancer Treated with Online Adaptive Radiotherapy: A Case Report[J]. Medical Journal of Peking Union Medical College Hospital. doi: 10.12290/xhyxzz.2023-0076
Citation: WANG Guangyu, YAN Junfang, WANG Zhiqun, ZHANG Yu, SUN Xiansong, LI Jing, LI Wenbo, YANG Bo, ZHANG Fuquan. Locally Advanced Cervical Cancer Treated with Online Adaptive Radiotherapy: A Case Report[J]. Medical Journal of Peking Union Medical College Hospital. doi: 10.12290/xhyxzz.2023-0076

在线自适应放疗技术治疗局部进展期宫颈癌一例

doi: 10.12290/xhyxzz.2023-0076
基金项目: 

国家重点研发计划(2022YFC2407100,2022YFC2407101,2022YFC2407102)

详细信息
    通讯作者:

    晏俊芳,E-mail:yanjunfang@pumch.cn

  • 中图分类号: R737.3;R815

Locally Advanced Cervical Cancer Treated with Online Adaptive Radiotherapy: A Case Report

Funds: 

National Key Research and Development Program of China (2022YFC2407100, 2022YFC2407101, 2022YFC2407102)

  • 摘要:

    在线自适应放疗( online adaptive radiotherapy,OART)技术是继调强放疗后的革命性技术,目前国内首个基于迭代锥形束CT( iterative cone beam computed tomography,iCBCT)的人工智能在线自适应放疗平台在北京协和医院被应用于临床治疗。本文报道北京协和医院放射治疗科首次采用基于iCBCT的OART技术治疗局部进展期宫颈癌患者1例,治疗后患者症状达到临床完全缓解且仅发生1级下消化道不良反应(腹泻),未出现1级及以上的血液学、泌尿生殖系统及其他放疗相关不良反应。本文就该患者的临床诊疗过程及随访展开讨论,以期为后续大规模应用该技术提供临床借鉴。

  • [1] Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020:GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries[J]. CA Cancer J Clin, 2021, 71:209-249.
    [2] Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68:394-424.
    [3] Naga Ch P, Gurram L, Chopra S, et al. The management of locally advanced cervical cancer[J]. Curr Opin Oncol, 2018, 30:323-329.
    [4] Klopp AH, Yeung AR, Deshmukh S, et al. Patient-Reported Toxicity During Pelvic IntensityModulated Radiation Therapy:NRG Oncology-RTOG 1203[J]. J Clin Oncol, 2018, 36:2538-2544.
    [5] Chopra S, Gupta S, Kannan S, et al. Late Toxicity After Adjuvant Conventional Radiation Versus Image-Guided Intensity-Modulated Radiotherapy for Cervical Cancer (PARCER):A Randomized Controlled Trial[J]. J Clin Oncol, 2021, 39:3682-3692.
    [6] Gandhi AK, Sharma DN, Rath GK, et al. Early clinical outcomes and toxicity of intensity modulated versus conventional pelvic radiation therapy for locally advanced cervix carcinoma:a prospective randomized study[J]. Int J Radiat Oncol Biol Phys, 2013, 87:542-548.
    [7] Jadon R, Pembroke CA, Hanna CL, et al. A systematic review of organ motion and image-guided strategies in external beam radiotherapy for cervical cancer[J]. Clin Oncol (R Coll Radiol), 2014, 26:185-196.
    [8] Barazzuol L, Coppes RP, van Luijk P. Prevention and treatment of radiotherapy-induced side effects[J]. Mol Oncol, 2020, 14:1538-1554.
    [9] Hale MF. Radiation enteritis:from diagnosis to management[J]. Curr Opin Gastroenterol, 2020, 36:208-214.
    [10] Åström LM, Behrens CP, Storm KS, et al. Online adaptive radiotherapy of anal cancer:Normal tissue sparing, target propagation methods, and first clinical experience[J]. Radiother Oncol, 2022, 176:92-98.
    [11] Christiansen RL, Dysager L, Hansen CR, et al. Online adaptive radiotherapy potentially reduces toxicity for high-risk prostate cancer treatment[J]. Radiother Oncol, 2022, 167:165-171.
    [12] Kerkhof EM, Raaymakers BW, van der Heide UA, et al. Online MRI guidance for healthy tissue sparing in patients with cervical cancer:an IMRT planning study[J]. Radiother Oncol, 2008, 88:241-249.
    [13] Bertelsen AS, Schytte T, Møller PK, et al. First clinical experiences with a high field 1.5 T MR linac[J]. Acta Oncol, 2019, 58:1352-1357.
    [14] Alongi F, Rigo M, Figlia V, et al. 1.5 T MR-guided and daily adapted SBRT for prostate cancer:feasibility, preliminary clinical tolerability, quality of life and patient-reported outcomes during treatment[J]. Radiat Oncol, 2020, 15:69.
    [15] de Jong R, Visser J, van Wieringen N, et al. Feasibility of Conebeam CT-based online adaptive radiotherapy for neoadjuvant treatment of rectal cancer[J]. Radiat Oncol, 2021, 16:136.
  • 加载中
计量
  • 文章访问数:  25
  • HTML全文浏览量:  1
  • PDF下载量:  14
  • 被引次数: 0
出版历程
  • 收稿日期:  2023-02-13
  • 录用日期:  2023-03-28
  • 网络出版日期:  2023-08-07

目录

    /

    返回文章
    返回

    【温馨提醒】近日,《协和医学杂志》编辑部接到作者反映,有多名不法人员冒充期刊编辑发送见刊通知,鼓动作者添加微信,从而骗取版面费的行为。特提醒您,本刊与作者联系的方式均为邮件通知或电话,稿件进度通知邮箱为:mjpumch@126.com,编辑部电话为:010-69154261,请提高警惕,谨防上当受骗!如有任何疑问,请致电编辑部核实。谢谢!